Cellosaurus DM-3 (CVCL_2019)

Cell line name DM-3
Synonyms DM3
Accession CVCL_2019
Resource Identification Initiative To cite this cell line use: DM-3 (RRID:CVCL_2019)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Doubling time: 54 hours (PubMed=23840376); ~50-60 hours (DSMZ).
Disease Pleural sarcomatoid mesothelioma (NCIt: C45663)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 62Y
Category Cancer cell line
STR profile Source(s): DSMZ; PubMed=25877200

Markers:
AmelogeninX,Y
CSF1PO10,11
D13S31711
D16S5399,13
D18S5112,15
D21S1129,30
D3S135815,16
D5S81812,13
D7S8208,10
D8S117911,15
FGA19,20
Penta D11,12
Penta E7,12
TH016
TPOX8
vWA16,17
Publications

PubMed=15372243; DOI=10.1007/s00418-004-0701-1
Philippeaux M.-M., Pache J.-C., Dahoun S., Barnet M., Robert J.-H., Mauel J., Spiliopoulos A.
Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.
Histochem. Cell Biol. 122:249-260(2004)

PubMed=23840376; DOI=10.1371/journal.pone.0065903
Szulkin A., Nilsonne G., Mundt F., Wasik A.M., Souri P., Hjerpe A., Dobra K.
Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.
PLoS ONE 8:E65903-E65903(2013)

Cross-references
Cell line collections DSMZ; ACC-595
Cell line databases/resources CCLE; DM3_PLEURA
Biological sample resources BioSample; SAMN03473059